249 related articles for article (PubMed ID: 30868509)
1. Protective effect of surface-modified berberine nanoparticles against LPS-induced neurodegenerative changes: a preclinical study.
Soudi SA; Nounou MI; Sheweita SA; Ghareeb DA; Younis LK; El-Khordagui LK
Drug Deliv Transl Res; 2019 Oct; 9(5):906-919. PubMed ID: 30868509
[TBL] [Abstract][Full Text] [Related]
2. Berberine Nanoencapsulation Attenuates Hallmarks of Scoplomine Induced Alzheimer's-Like Disease in Rats.
Saleh SR; Abady MM; Nofal M; Yassa NW; Abdel-Latif MS; Nounou MI; Ghareeb DA; Abdel-Monaem N
Curr Rev Clin Exp Pharmacol; 2021; 16(2):139-154. PubMed ID: 32598269
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory efficacy of Berberine Nanomicelle for improvement of cerebral ischemia: formulation, characterization and evaluation in bilateral common carotid artery occlusion rat model.
Azadi R; Mousavi SE; Kazemi NM; Yousefi-Manesh H; Rezayat SM; Jaafari MR
BMC Pharmacol Toxicol; 2021 Oct; 22(1):54. PubMed ID: 34600570
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the protective effects of CS/TPP and CS/HPMCP nanoparticles containing berberine in ethanol-induced hepatotoxicity in rat.
Mahboubi Kancha M; Alizadeh M; Mehrabi M
BMC Complement Med Ther; 2024 Jan; 24(1):39. PubMed ID: 38225618
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory effect of PLGA-encapsulated berberine on hepatotoxicity and α-smooth muscle actin (α-SMA) gene expression.
Ahrari A; Najafzadehvarzi H; Taravati A; Tohidi F
Life Sci; 2021 Nov; 284():119884. PubMed ID: 34389401
[TBL] [Abstract][Full Text] [Related]
7. In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis.
Zhou Y; Liu SQ; Peng H; Yu L; He B; Zhao Q
Int Immunopharmacol; 2015 Sep; 28(1):34-43. PubMed ID: 26002585
[TBL] [Abstract][Full Text] [Related]
8. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
Hanafy AS; Farid RM; ElGamal SS
Drug Dev Ind Pharm; 2015; 41(12):2055-68. PubMed ID: 26133084
[TBL] [Abstract][Full Text] [Related]
9. Sustained release effects of berberine-loaded chitosan microspheres on in vitro chondrocyte culture.
Zhou Y; Liu S; Ming J; Li Y; Deng M; He B
Drug Dev Ind Pharm; 2017 Oct; 43(10):1703-1714. PubMed ID: 28585864
[TBL] [Abstract][Full Text] [Related]
10. PEG-lipid-PLGA hybrid nanoparticles loaded with berberine-phospholipid complex to facilitate the oral delivery efficiency.
Yu F; Ao M; Zheng X; Li N; Xia J; Li Y; Li D; Hou Z; Qi Z; Chen XD
Drug Deliv; 2017 Nov; 24(1):825-833. PubMed ID: 28509588
[TBL] [Abstract][Full Text] [Related]
11. Combined ROS Responsive Polydopamine-Coated Berberine Nanoparticles Effective Against Ulcerative Colitis in Mouse Model.
Chang C; Liu H; Li X; Song D; Liu Y; Lu C; Zhen Y; Chen Y; Xu J; Li W; Jia X; Chen Z; Chen R
Int J Nanomedicine; 2024; 19():1205-1224. PubMed ID: 38348171
[TBL] [Abstract][Full Text] [Related]
12. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
13. Fabrication, characterization and optimization of berberine-loaded PLA nanoparticles using coaxial electrospray for sustained drug release.
Ghaffarzadegan R; Khoee S; Rezazadeh S
Daru; 2020 Jun; 28(1):237-252. PubMed ID: 32307652
[TBL] [Abstract][Full Text] [Related]
14. Lipid-Coated MCM-41 Mesoporous Silica Nanoparticles Loaded with Berberine Improved Inhibition of Acetylcholine Esterase and Amyloid Formation.
Singh AK; Singh SS; Rathore AS; Singh SP; Mishra G; Awasthi R; Mishra SK; Gautam V; Singh SK
ACS Biomater Sci Eng; 2021 Aug; 7(8):3737-3753. PubMed ID: 34297529
[TBL] [Abstract][Full Text] [Related]
15. Berberine nanoparticles protects tubular epithelial cells from renal ischemia-reperfusion injury.
Xie D; Xu Y; Jing W; Juxiang Z; Hailun L; Yu H; Zheng DH; Lin YT
Oncotarget; 2017 Apr; 8(15):24154-24162. PubMed ID: 28445993
[TBL] [Abstract][Full Text] [Related]
16. Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of berberine in rats.
Chen W; Fan D; Meng L; Miao Y; Yang S; Weng Y; He H; Tang X
Drug Dev Ind Pharm; 2012 Jan; 38(1):104-10. PubMed ID: 21774632
[TBL] [Abstract][Full Text] [Related]
17. Development and In Vitro Evaluation of Linear PEI-Shelled Heparin/Berberine Nanoparticles in Human Osteosarcoma U-2 OS Cells.
Hsu HK; Hsu KH; Cheng YM; Suen HY; Peng SF
Molecules; 2018 Nov; 23(12):. PubMed ID: 30487471
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB expression, ameliorated BBB permeability.
Zhang X; Zhang X; Wang C; Li Y; Dong L; Cui L; Wang L; Liu Z; Qiao H; Zhu C; Xing Y; Cao X; Ji Y; Zhao K
Brain Res; 2012 Jun; 1459():61-70. PubMed ID: 22560097
[TBL] [Abstract][Full Text] [Related]
19. Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics.
Gupta L; Sharma AK; Gothwal A; Khan MS; Khinchi MP; Qayum A; Singh SK; Gupta U
Int J Pharm; 2017 Aug; 528(1-2):88-99. PubMed ID: 28533175
[TBL] [Abstract][Full Text] [Related]
20. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
